featured-image-standard-abstract-lines-dots-nodes-connecting

FDA cracking down on illegally marketed dietary supplements

Written by Joseph Nordqvist

Published: 23:16, February 11, 2019

The US Food and Drug Administration (FDA) sent warning letters to 12 companies “illegally” marketing dietary supplements to stop claiming, without proof, that their products can prevent, treat or cure Alzheimer’s disease, diabetes and cancer.

The FDA said in a press release that many of the targeted products haven’t been reviewed by the FDA and “are not proven safe and effective to treat the diseases and health conditions they claim to treat.”

“These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment,” the agency added.

FDA will update its policies on dietary supplements

In an official statement, FDA Commissioner Dr. Scott Gottlieb promised “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years.”

The dietary supplement industry is currently worth an estimated $40 billion with tens of thousands of different products for consumers. The majority of American consumers, an estimated three quarters, take dietary supplements on a regular basis.

“In the 25 years since Congress passed the Dietary Supplement Health and Education Act (DSHEA), the law that transformed the FDA’s authority to regulate dietary supplements, the dietary supplement market has grown significantly,” said FDA Commissioner Scott Gottlieb, M.D.

While most businesses in the industry act responsibly there is an increasing number of entities selling dangerous products or making unproven claims about the health benefits of their products.

“DSHEA imposes a number of requirements around the manufacture and labeling of dietary supplements. We know that most players in this industry act responsibly. But there are opportunities for bad actors to exploit the halo created by quality work of legitimate manufacturers to instead distribute and sell dangerous products that put consumers at risk,” Gottlieb added.

“As the popularity of supplements has grown, so have the number of entities marketing potentially dangerous products or making unproven or misleading claims about the health benefits they may deliver.”

Gottlieb said plans are already underway for “new enforcement strategies” and “a new rapid-response tool to alert the public” of unsafe products. Further details will be announced “in the coming months.”

A study, published in October last year, identified nearly 800 over-the-counter dietary supplements that contained unapproved drug ingredients between 2007 and 2016.

 

Joseph Nordqvist Avatar

Other News

Shoppers judge returns policies before they place an order

Oct 25, 2026

A four-star average can hide very different customer experiences

Oct 25, 2026

Used EV battery checks give buyers evidence beyond mileage

Oct 25, 2026

Extra green products can win more credit than waste reduction

Oct 25, 2026

Higher revenue per worker leaves the wage question unanswered

Oct 25, 2026

Removing noncompetes increased recruiters’ mobility and earnings

Oct 25, 2026

A retailer’s margin can decide whether new products reach customers

Oct 24, 2026

Better financial protection can coexist with more credit-card borrowing

Oct 24, 2026

Managers misjudged incentive contracts in mobile-money experiment

Oct 24, 2026

Colorado River study challenges assumptions about groundwater reserves

Oct 24, 2026

Mortgage fee cuts often fail to reach homebuyers in full, study finds

Oct 24, 2026

Company size can hide where supply-chain risks sit

Oct 24, 2026

Employee training depends on how a company organizes work

Oct 24, 2026

AI improved patent drafts, but lasting skill gains depended on experience

Oct 23, 2026

Global risk appetite can put company investment on hold

Oct 23, 2026

France’s shorter working week raised productivity without adding jobs at firms

Oct 23, 2026

Venture capital increasingly backs the business of winning customers

Oct 23, 2026

Travel choices and toll revenue shape the gains from congestion pricing

Oct 23, 2026

The cost of losing a job can shape who joins a young company

Oct 23, 2026

Pension payouts can turn patient investors into regular stock sellers

Oct 23, 2026